News & Events category:
Manchester Royal Infirmary

Manchester research links two types of less-often prescribed diabetes drugs with lower chances of potentially fatal heart problems – in people with type 2 diabetes without established heart disease.

A study led by Manchester University NHS Foundation Trust (MFT) and The University of Manchester researchers has revealed that obesity is likely to cause an increased risk of kidney disease.

Advances in technology and data from pacemakers are alerting Manchester doctors of heart failure patients who may benefit from medical attention.

A new trial opens in Greater Manchester today which is to test cutting-edge wearable technologies involving patients who have received cancer treatment.

Ground-breaking research taking place at Manchester University NHS Foundation Trust is investigating a pioneering new treatment for COVID-19.

The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.

A trainee surgeon at Manchester Royal Infirmary (MRI) was recently awarded a prestigious national honour for his contributions to transplant research.

Children with adrenal insufficiency have a higher risk of dying than those with other lifelong conditions, according to research by The University of Manchester and MFT scientists.